PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Alan Kohler is 70 years of age.Our target market will be from...

  1. 9,705 Posts.
    lightbulb Created with Sketch. 1234
    Alan Kohler is 70 years of age.

    Our target market will be from age 45 onwards to defer the need for such invasive surgery. Getting it too early ends very poorly for a large percentage of patients given it then requires much more complex rectification surgery at later stages of life. Most doctors know this and will be shown something that provides a safe and highly effective alternative.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.